Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.
about
Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk.2-hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1.Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC.
P2860
Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@ast
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@en
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@nl
type
label
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@ast
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@en
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@nl
prefLabel
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@ast
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@en
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@nl
P2093
P2860
P1433
P1476
Characterization of hydroxypro ...... Niemann-Pick Disease type C1.
@en
P2093
Allan J Darling
Forbes D Porter
Paul S Blank
Peter S Backlund
Stephanie M Cologna
P2860
P304
P356
10.1371/JOURNAL.PONE.0175478
P407
P577
2017-04-17T00:00:00Z